Susquehanna International Group’s INmune Bio INMB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$19.8K Sell
17,500
-21,400
-55% -$30.5K ﹤0.01% 12863
2025
Q4
$60.7K Sell
38,900
-57,300
-60% -$102K ﹤0.01% 11690
2025
Q3
$199K Sell
96,200
-676,400
-88% -$1.55M ﹤0.01% 10999
2025
Q2
$1.78M Buy
772,600
+663,300
+607% +$4.87M ﹤0.01% 6041
2025
Q1
$854K Sell
109,300
-30,500
-22% -$242K ﹤0.01% 7653
2024
Q4
$653K Sell
139,800
-73,600
-34% -$384K ﹤0.01% 8014
2024
Q3
$1.15M Buy
213,400
+145,800
+216% +$1.04M ﹤0.01% 6469
2024
Q2
$596K Buy
67,600
+44,400
+191% +$438K ﹤0.01% 7847
2024
Q1
$273K Sell
23,200
-12,500
-35% -$151K ﹤0.01% 9918
2023
Q4
$402K Buy
35,700
+20,800
+140% +$174K ﹤0.01% 9168
2023
Q3
$102K Sell
14,900
-900
-6% -$7.46K ﹤0.01% 10905
2023
Q2
$143K Buy
+15,800
New +$127K ﹤0.01% 10619
2023
Q1
Sell
-10,100
Closed -$64K 13012
2022
Q4
$64K Sell
10,100
-11,500
-53% -$81.6K ﹤0.01% 11259
2022
Q3
$134K Sell
21,600
-4,900
-18% -$43K ﹤0.01% 11393
2022
Q2
$234K Buy
+26,500
New +$197K ﹤0.01% 10237
2021
Q4
Sell
-41,400
Closed -$804K 13471
2021
Q3
$804K Buy
+41,400
New +$799K ﹤0.01% 8117

Other funds holding INMB

Susquehanna International Group's INMB Position: Q1 2026 in Review

Susquehanna International Group reduced its INmune Bio (INMB) stake by 23% in Q1 2026, selling an estimated $80.5K and leaving 194,391 shares worth $220K. The position accounts for ﹤0.01% of the portfolio, ranked #11508.

Susquehanna International Group first reported a position in INMB in Q1 2020 and has held it in 20 quarters since. The position peaked at $1.82M in Q1 2024. 82 funds tracked by Wall St. Rank hold INMB as of Q1 2026.

  • Susquehanna International Group held 194,391 shares of INmune Bio worth $220K as of Q1 2026.
  • Susquehanna International Group sold 56,519 INmune Bio shares in Q1 2026, an estimated $80.5K.
  • INmune Bio made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #11508 holding.
  • Susquehanna International Group first reported a position in INmune Bio in Q1 2020 and has held it in 20 quarters since.
  • Susquehanna International Group's INmune Bio position peaked at $1.82M in Q1 2024.
  • 82 funds tracked by Wall St. Rank held INmune Bio as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.